Insulet (PODD) Other Non Operating Income (2011 - 2026)
Insulet's (PODD) quarterly Other Non Operating Income came in at -$1.1 million in Q2 2026, up 98.7% on a YoY basis from -$553607.6 in Q2 2025, and down 257.14% quarter-over-quarter from $700000.0 in Q1 2026.
Analysis
Insulet (PODD) Other Non Operating Income (2011 - 2026) Analysis & Trends
Insulet (PODD) has reported Other Non Operating Income for 16 consecutive years, with -$1.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income rose 98.7% year-over-year to -$1.1 million; the trailing twelve-month figure through Jun 2026 stood at $11.7 million (up 109.22% YoY), and the FY2025 full-year result was -$123.9 million, down 2152.73% from the prior year.
- Other Non Operating Income declined to -$1.1 million in Q2 2026 per PODD's latest filing, from $700000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $12.1 million in Q3 2025 and bottomed at -$84.4 million in Q2 2025.
- Historically, Other Non Operating Income has averaged -$6.9 million across 5 years, with a median of -$200000.0 in 2023.
- The widest YoY moves for Other Non Operating Income: up 455.88% in 2025, down 5542.86% in 2025.
- Over 5 years, Other Non Operating Income stood at $1.5 million in 2022, then gained by 26.67% to $1.9 million in 2023, then plunged by 78.95% to $400000.0 in 2024, then surged by 2925.0% to $12.1 million in 2025, then slumped by 109.09% to -$1.1 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$1.1 million, $700000.0, and $12.1 million for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Insulet | 9.33 Bn | 8.79 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 Mn |
| Mar 31, 2026 | 700,000.00 |
| Sep 30, 2025 | 12.10 Mn |
| Jun 30, 2025 | -84.40 Mn |
| Mar 31, 2025 | -39.50 Mn |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | -3.40 Mn |
| Jun 30, 2024 | -1.80 Mn |
| Mar 31, 2024 | -700,000.00 |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | -1.80 Mn |
| Jun 30, 2022 | -1.10 Mn |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | -800,000.00 |
| Sep 30, 2021 | -1.50 Mn |
| Jun 30, 2021 | -40.10 Mn |